Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fludarabine Versus Chlorambucil in First Line Therapy of Elderly Patients (More Than 65 Years) With Advanced Chronic Lymphocytic Leukemia

NCT00262795 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00262795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fludarabine Versus Chlorambucil in First Line Therapy of Elderly Patients (More Than 65 Years) With Advanced Chronic Lymphocytic Leukemia
Lead sponsor
German CLL Study Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
October 31, 2005
Enrollment
206 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia